Pricing Log in Create free account

Milestone Pharmaceuticals Inc. (MIST) vs VAXART, INC. (VXRT)

Milestone Pharmaceuticals Inc. and VAXART, INC. are both Biotechnology companies. Milestone Pharmaceuticals Inc. and VAXART, INC. are of similar size ($96.2M and $92.4M). Milestone Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (16.0% vs −1,586.0%) and the higher return on invested capital (2,542.3% vs 0.00%). Across the 17 metrics below, VAXART, INC. leads on 14 and Milestone Pharmaceuticals Inc. on 3.

Valuation

Metric MIST VXRT Biotechnology median
P/E n/m 2.85 10.26
P/S 18.07 0.50 9.18
P/B 5.25 1.36 2.05
Price to free cash flow n/m 2.81 24.81
EV/EBITDA 0.20 0.56 0.65
EV/Sales (2.96) 0.14 8.98
Earnings yield (100.00%) 35.14% (34.89%)
Free cash flow yield (64.42%) 35.55% (24.52%)

Profitability

Metric MIST VXRT Biotechnology median
Gross margin 13.27% 100.00% 65.16%
Operating margin (1,479.69%) 16.63% 0.00%
Net margin (1,586.01%) 16.02% 0.00%
Free cash flow margin (1,163.79%) 17.64% 0.00%
Return on equity (35,522.62%) 62.42% (50.12%)
Return on assets (73.36%) 16.26% (45.60%)
Return on invested capital 0.00% 2,542.26% 0.00%

Growth

Metric MIST VXRT Biotechnology median
Revenue growth (TTM) — 22.31% 6.26%
EPS growth (last fiscal year) (11.94%) 121.21% 29.88%
Revenue growth, 5-year CAGR — 125.76% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MIST VXRT Biotechnology median
Debt to equity 3.25 0.00 0.00
Current ratio 8.13 1.71 4.89
Net debt to EBITDA 0.79 (2.42) 1.01

Dividend

Metric MIST VXRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric MIST VXRT Biotechnology median
Market cap 96.17m 92.41m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack